Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 9cemiplimab 7Nivolumab 7Ipilimumab 6Blood Specimen Collection 4lifileucel 2encorafenib 2binimetinib 2avelumab 2aldesleukin 2Specimen Handling 2Niacinamide 2Cyclophosphamide 2toripalimab 1tislelizumab 1relatlimab 1oxycodone-acetaminophen 1lenvatinib 1lavender oil 1fludarabine 1epacadostat 1durvalumab 1dostarlimab 1brodalumab 1atezolizumab 1Water 1Vitamin A 1Tissue Banks 1Surgical Procedures, Operative 1Sunscreening Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Sunscreening Agents × 90 days × Clear all
NCT07286318 2026-04-02

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

University of Pittsburgh

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡